FBIOX: Fidelity® Select Biotechnology
Advisor Access
Home
Screener
Top Funds
Categories
News
Articles
Advisors
Fund Companies

Welcome to MutualFunds.com. Please help us personalize your experience.

Select the one that best describes you

Thank you!

Check your email and confirm your subscription to complete your personalized experience.

Thank you for your submission, we hope you enjoy your experience

You have successfully subscribed to Advisor Access. Thank you!
Help us personalize your experience.
Which type of investor describes you best?
Help us personalize your experience.
What is your AUM?
Knowing your investable assets will help us build and prioritize features that will suit your investment needs.

Congratulations on personalizing your experience.

Email is verified. Thank you!

FBIOX Fidelity® Select Biotechnology

  • Fund
  • FBIOX
  • Price as of: Oct 15, 2019
  • $18.85 + $0.42 + 2.28%
Profile Categories Quick Screens Performance Holdings Expenses Distributions Managers Read Next

FBIOX - Profile

Vitals

  • YTD Return 6.3%
  • 3 Yr Annualized Return 2.4%
  • 5 Yr Annualized Return -1.9%
  • Net Assets $6.04 B
  • Holdings in Top 10 39.2%

52 WEEK LOW AND HIGH

$18.85
$16.34
$22.21

Expenses

OPERATING RELATED FEES

  • Expense Ratio 0.72%

SALES FEES

  • Front Load N/A
  • Deferred Load N/A

BROKERAGE FEES

  • Turnover 37.00%

TRADING FEES

  • Max Redemption Fee 0.75%

Min Investment

STANDARD (TAXABLE)

$0

IRA

$2,500

Fund Classification

PRIMARY CATEGORY

Healthcare & Biotech Equity
  • Fund Type Open End Mutual Fund
  • Investment Style Health

Distributions

  • YTD Total Return 6.3%
  • 3 Yr Annualized Total Return 4.3%
  • 5 Yr Annualized Total Return 3.5%
  • Capital Gain Distribution Frequency Semi-Annually
  • Net Income Ratio -0.20%
DIVIDENDS
  • Dividend Yield 0.0%
  • Dividend Distribution Frequency Annually

Fund Details

  • Legal Name Fidelity® Select Biotechnology Portfolio
  • Fund Family Name Fidelity Investments
  • Inception Date Dec 16, 1985
  • Shares Outstanding N/A
  • Share Class No Load
  • Currency USD
  • Domiciled Country United States
  • Manager Rajiv Kaul

Fund Description

Fidelity Select Biotechnology Portfolio (FBIOX) is an actively managed mutual fund managed by Fidelity. The fund is focused primarily on the biotechnology industry and its operations. It is compiled primarily of U.S. common stocks in the healthcare industry with some exposure to the services industries. In general, this fund tends to have 80% of its holdings in stocks that are focused in research, development, manufacturing, and distribution of biotechnological products, services, processes and companies. The fund has been managed by Rajiv Kaul since 2005 and was launched on December 16, 1985.

The fund is very focused on capital appreciation but carries a higher amount of risk since it is sector-focused and has little diversification. The fund holds additional risk since the companies are affected by patent considerations, high competition, technological changes and government regulations. Despite its risk, the biotechnology industry is well known for its high risk and reward and may be ideal for aggressive investors seeking growth and high returns in their portfolio. In addition, sector based mutual funds such as the Fidelity Select Biotechnology Portfolio may be a good alternative for investors seeking exposure to the biotechnology industry without buying specific stocks.

Holdings in this fund are generally large cap growth stocks. The fund’s holdings are determined by analyzing drug pipelines, the size of market opportunities and the valuations. Typically, this fund holds long term growth stocks, companies with attractive drug pipelines, turnaround companies, breakthrough companies and startups.

The fund’s holdings are chosen by using various factors including financial conditions, industry position, and current economic and market conditions. This fund aims to outperform the benchmark through its active management. The fund pays dividends and capital gains every year in April and December.

This fund requires a minimum initial investment of $2,500 for both regular and IRA accounts.

FBIOX - Mutual Fund Categories

Developed Market
North America
Active
No Load
U.S.
North America Equity
Healthcare & Biotech Equity
All Cap Equity
U.S. All Cap Equity

FBIOX - Fund Company Quick Screens

Fidelity Healthcare Equity Funds

FBIOX - Performance

Return Ranking - Trailing

Period FBIOX Return Category Return Low Category Return High Rank in Category (%)
YTD 6.3% -3.8% 16.5% 70.94%
1 Yr -16.4% -27.6% 2.7% 86.32%
3 Yr 2.4%* -15.3% 15.2% 58.72%
5 Yr -1.9%* -10.4% 12.6% 72.55%
10 Yr 11.1%* -2.7% 16.3% 24.42%

* Annualized

Return Ranking - Calendar

Period FBIOX Return Category Return Low Category Return High Rank in Category (%)
2018 -19.1% -25.3% 21.5% 92.79%
2017 26.1% -10.8% 43.9% 11.93%
2016 -26.2% -31.6% 6.9% 96.23%
2015 6.6% -20.4% 13.8% 9.71%
2014 21.8% -5.8% 31.5% 27.08%

Total Return Ranking - Trailing

Period FBIOX Return Category Return Low Category Return High Rank in Category (%)
YTD 6.3% -3.8% 16.5% 70.94%
1 Yr -16.4% -27.6% 2.7% 87.18%
3 Yr 4.3%* -15.3% 17.3% 58.72%
5 Yr 3.5%* -10.4% 18.1% 55.88%
10 Yr 15.0%* -2.7% 16.7% 17.44%

* Annualized

Total Return Ranking - Calendar

Period FBIOX Return Category Return Low Category Return High Rank in Category (%)
2018 -15.8% -25.3% 22.2% 87.39%
2017 27.9% -10.8% 45.8% 11.01%
2016 -23.8% -26.4% 8.7% 94.34%
2015 13.9% -16.6% 15.2% 4.85%
2014 36.7% -5.8% 36.7% 1.04%

NAV & Total Return History

FBIOX - Holdings

Concentration Analysis

FBIOX Category Low Category High FBIOX % Rank
Net Assets 6.04 B 2.52 M 42.7 B 11.02%
Number of Holdings 243 28 390 2.36%
Net Assets in Top 10 2.53 B 807 K 17.9 B 11.02%
Weighting of Top 10 39.24% 20.8% 76.5% 57.48%

Top 10 Holdings

  1. AbbVie Inc 8.89%
  2. Amgen Inc 8.06%
  3. Vertex Pharmaceuticals Inc 4.81%
  4. Gilead Sciences Inc 3.60%
  5. Alexion Pharmaceuticals Inc 3.33%
  6. Neurocrine Biosciences Inc 2.43%
  7. Sage Therapeutics Inc 2.25%
  8. Regeneron Pharmaceuticals Inc 2.08%
  9. Ionis Pharmaceuticals Inc 1.92%
  10. Alnylam Pharmaceuticals Inc 1.86%

Asset Allocation

Weighting Return Low Return High FBIOX % Rank
Stocks 		97.03% 90.21% 103.54% 67.72%
Other 		1.41% -27.41% 3.81% 11.81%
Preferred Stocks 		0.96% 0.00% 2.60% 7.09%
Cash 		0.59% 0.00% 9.79% 70.87%
Convertible Bonds 		0.00% 0.00% 1.54% 66.93%
Bonds 		0.00% 0.00% 20.60% 66.93%

Stock Sector Breakdown

Weighting Return Low Return High FBIOX % Rank
Healthcare 		96.79% 56.60% 99.76% 26.77%
Utilities 		0.00% 0.00% 0.00% 63.78%
Technology 		0.00% 0.00% 22.28% 85.83%
Real Estate 		0.00% 0.00% 5.81% 64.57%
Industrials 		0.00% 0.00% 3.11% 74.02%
Financial Services 		0.00% 0.00% 5.48% 68.50%
Energy 		0.00% 0.00% 0.31% 66.14%
Communication Services 		0.00% 0.00% 2.11% 63.78%
Consumer Defense 		0.00% 0.00% 33.15% 65.35%
Consumer Cyclical 		0.00% 0.00% 5.27% 68.50%
Basic Materials 		0.00% 0.00% 1.68% 77.95%

Stock Geographic Breakdown

Weighting Return Low Return High FBIOX % Rank
US 		90.79% 59.25% 99.76% 17.32%
Non US 		6.24% 0.00% 40.06% 82.68%

FBIOX - Expenses

Operational Fees

FBIOX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 0.72% 0.10% 4.94% 92.31%
Management Fee 0.54% 0.09% 1.30% 8.66%
12b-1 Fee N/A 0.00% 1.00% N/A
Administrative Fee N/A 0.01% 0.40% N/A

Sales Fees

FBIOX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 2.50% 5.75% N/A
Deferred Load N/A 1.00% 5.00% N/A

Trading Fees

FBIOX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee 0.75% 0.75% 2.00% 82.93%

Turnover Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

FBIOX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover 37.00% 0.00% 341.00% 44.92%

FBIOX - Distributions

Dividend Yield Analysis

FBIOX Category Low Category High FBIOX % Rank
Dividend Yield 0.00% 0.00% 4.42% 65.35%

Dividend Distribution Analysis

FBIOX Category Low Category High Category Mode
Dividend Distribution Frequency Annually Annually Quarterly Annually

Dividend Payout History

View More History

Net Income Ratio Analysis

FBIOX Category Low Category High FBIOX % Rank
Net Income Ratio -0.20% -2.24% 1.48% 54.70%

Capital Gain Distribution Analysis

FBIOX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Semi-Annually Annually Annually Annually

FBIOX - Managers

Rajiv Kaul

Manager

Start Date

Tenure

Tenure Rank

Oct 12, 2005

13.98

14.0%

Kaul is a portfolio manager with Fidelity Investments. Since joining Fidelity Investments in 1996, he has worked as a research analyst and portfolio manager. Kaul also manages another Fidelity fund. Prior to Fidelity, Kaul worked at Mckinsey & Company. He is the recipient of the Kann Rasmusson Environment Award, the Dean's Summer Research Award and a Ford Undergraduate Fellowship.

Tenure Analysis

Category Low

0.34

Category High

22.05

Category Average

9.62

Category Mode

19.43

Advertisement

×

Wait! Do you know all the important aspects of mutual funds?

×
X